{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:09:57Z","timestamp":1760170197371,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.maturitas.2005.01.004","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T10:15:25Z","timestamp":1107857725000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis"],"prefix":"10.1016","volume":"52","author":[{"given":"Anette L\u00f8ken","family":"Eilertsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Else","family":"H\u00f8ibraaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine Opstad","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiv","family":"Sandvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Morten","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.maturitas.2005.01.004_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.maturitas.2005.01.004_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.maturitas.2005.01.004_bib3","first-page":"961","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy\u2014results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib4","first-page":"1218","article-title":"Hormone replacement therapy with estradiol and risk of venous thromboembolism\u2014a population-based case\u2013control study","volume":"82","author":"Hoibraaten","year":"1999","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.maturitas.2005.01.004_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2005.01.004_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"Hormone replacement therapy, heart disease, and other considerations","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"10.1016\/j.maturitas.2005.01.004_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1365-2796.2001.00910.x","article-title":"Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women","volume":"250","author":"Guzic-Salobir","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.maturitas.2005.01.004_bib8","doi-asserted-by":"crossref","unstructured":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995;273(3):199\u2013208.","DOI":"10.1001\/jama.1995.03520270033028"},{"issue":"6","key":"10.1016\/j.maturitas.2005.01.004_bib9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1055\/s-0037-1613947","article-title":"Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease","volume":"83","author":"Seljeflot","year":"2000","journal-title":"Thromb Haemost"},{"issue":"23","key":"10.1016\/j.maturitas.2005.01.004_bib10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.maturitas.2005.01.004_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.maturitas.2005.01.004_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.maturitas.2005.01.004_bib13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.maturitas.2005.01.004_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.maturitas.2005.01.004_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Study","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.maturitas.2005.01.004_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0021-9150(03)00088-1","article-title":"Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis","volume":"168","author":"Zegura","year":"2003","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.maturitas.2005.01.004_bib17","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jcem.86.8.7768","article-title":"Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women","volume":"86","author":"Luyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.19.4.893","article-title":"Hormone replacement therapy, inflammation, and hemostasis in elderly women","volume":"19","author":"Cushman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.maturitas.2005.01.004_bib19","first-page":"124","article-title":"Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein","volume":"90","author":"Lacut","year":"2003","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-0037-1613263","article-title":"Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial","volume":"88","author":"Post","year":"2002","journal-title":"Thromb Haemost"},{"issue":"24","key":"10.1016\/j.maturitas.2005.01.004_bib22","doi-asserted-by":"crossref","first-page":"198e","DOI":"10.1161\/01.CIR.0000041808.84600.F6","article-title":"Statin Attenuates Increase in C-reactive protein during estrogen replacement therapy in postmenopausal women * response","volume":"106","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.maturitas.2005.01.004_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1067\/mob.2002.122414","article-title":"Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations","volume":"186","author":"Skouby","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.maturitas.2005.01.004_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9150(02)00242-3","article-title":"The effect of 17 beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial","volume":"165","author":"Stork","year":"2002","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2796.2000.00675.x","volume":"247","author":"Os","year":"2000","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.maturitas.2005.01.004_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism\u2014results from a randomized, double-blind, clinical trial","volume":"85","author":"Hoibraaten","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.maturitas.2005.01.004_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(99)00233-9","article-title":"The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study","volume":"98","author":"Hoibraaten","year":"2000","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.maturitas.2005.01.004_bib28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.maturitas.2005.01.004_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2796.2000.00648.x","article-title":"Increased plasma concentrations of TGF-beta1 after hormone replacement therapy","volume":"247","author":"Djurovic","year":"2000","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.maturitas.2005.01.004_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","article-title":"Hormone replacement therapy and increased plasma concentration of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.maturitas.2005.01.004_bib31","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/01.ATV.0000029781.31325.66","article-title":"Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women","volume":"22","author":"Bermudez","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.maturitas.2005.01.004_bib32","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(00)00952-9","article-title":"Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management","volume":"36","author":"Zanger","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0015-0282(98)00513-5","article-title":"Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women","volume":"71","author":"van Baal","year":"1999","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.maturitas.2005.01.004_bib34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0037-1614600","article-title":"Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women","volume":"81","author":"van Baal","year":"1999","journal-title":"Thromb Haemost"},{"issue":"25","key":"10.1016\/j.maturitas.2005.01.004_bib35","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/01.CIR.0000074208.02226.5E","article-title":"Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response","volume":"107","author":"Silvestri","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.maturitas.2005.01.004_bib36","doi-asserted-by":"crossref","first-page":"R1253","DOI":"10.1152\/ajpregu.00170.2003","article-title":"C-reactive protein and atherothrombosis\u2014beyond a biomarker: an actual partaker of lesion formation","volume":"285","author":"Verma","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"10.1016\/j.maturitas.2005.01.004_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study","volume":"109","author":"Clarke","year":"2002","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.maturitas.2005.01.004_bib38","first-page":"730","article-title":"C-reactive protein, idiopathic venous thromboembolism and hormone replacement therapy","volume":"84","author":"Lowe","year":"2000","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.maturitas.2005.01.004_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrc1208","article-title":"Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer","volume":"3","author":"Siegel","year":"2003","journal-title":"Nat Rev Cancer"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:40:22Z","timestamp":1759912822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512205000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0378512205000071"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.01.004","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}